BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $286,000 | -36.0% | 27,000 | -1.8% | 0.02% | -21.7% |
| Q1 2022 | $447,000 | +16.1% | 27,500 | -1.2% | 0.02% | +9.5% |
| Q4 2021 | $385,000 | -5.4% | 27,824 | -1.8% | 0.02% | -8.7% |
| Q3 2021 | $407,000 | -9.2% | 28,324 | 0.0% | 0.02% | -14.8% |
| Q2 2021 | $448,000 | +52.9% | 28,324 | -1.7% | 0.03% | +92.9% |
| Q1 2021 | $293,000 | +5.8% | 28,824 | -22.5% | 0.01% | 0.0% |
| Q4 2020 | $277,000 | +307.4% | 37,200 | +88.8% | 0.01% | +133.3% |
| Q3 2020 | $68,000 | +240.0% | 19,700 | +369.0% | 0.01% | +200.0% |
| Q2 2020 | $20,000 | – | 4,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |